Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says | Page 12 | Unpublished
Hello!
Source Feed: Global News - Canada
Author: Globalnews Digital
Publication Date: July 16, 2026 - 09:35

Stay informed

Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says

July 16, 2026
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease.